CSIMarket
 


Coherus Biosciences inc   (CHRS)
Other Ticker:  
 

Coherus Biosciences Inc 's Leverage Ratio

CHRS's quarterly Leverage Ratio and Total Liabilities, Equity growth


In IV Quarter 2023 Coherus Biosciences Inc had stockholder deficit.

Within Biotechnology & Pharmaceuticals industry Coherus Biosciences inc achieved the lowest Leverage Ratio in the forth quarter 2023. While total ranking remained the same in the forth quarter 2023 compared to the previous quarter at no. .

Explain Leverage Ratio?
Who are CHRS Customers?
What are CHRS´s Total Liabilities?


CHRS Leverage Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change - - - - -
Y / Y Total Liabilities Change 33.12 % 10.7 % 13.32 % 3.12 % 24.82 %
Leverage Ratio MRQ - - - - -
CHRS's Total Ranking # # # # #
Seq. Equity Change - - - - -
Seq. Total Liabilities Change 14.73 % 11.33 % 7.58 % -3.13 % -4.59 %



Leverage Ratio forth quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Coherus Biosciences Inc 's Equity $ -193 Millions Visit CHRS's Balance sheet
Coherus Biosciences Inc 's Total Liabilities $ 823 Millions Visit CHRS's Balance sheet
Source of CHRS's Sales Visit CHRS's Sales by Geography


Cumulative Coherus Biosciences Inc 's Leverage Ratio

CHRS's Leverage Ratio for the trailling 12 Months

CHRS Leverage Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth - - - - -
Y / Y Total Liabilities TTM Growth 33.12 % 10.7 % 13.32 % 3.12 % 24.82 %
Leverage Ratio TTM - - - - -
Total Ranking TTM
Seq. Equity TTM Growth - - - - -
Seq. Total Liabilities TTM Growth 14.73 % 11.33 % 7.58 % -3.13 % -4.59 %


On the trailing twelve months basis During the 12 months period ending IV Quarter 2023 company had stockholder deficit.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry CHRS recorded the lowest Leverage Ratio. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Leverage Ratio?
Who are CHRS Customers?
What are CHRS´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Within the Market #


trailing twelve months Leverage Ratio Statistics
High Average Low
0 0 0
 




Companies with similar Leverage Ratio in the quarter ending Dec 31 2023, within Biotechnology & Pharmaceuticals Industry Leverage RatioDec 31 2023 MRQ Total LiabilitiesDec 31 2023 MRQ Equity

Date modified: 2024-03-18T20:14:54+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com